Concepedia

Vidyalakshmi Chandramohan

VC

Statistics

Publications

15

Citations

1.3K

H-Index

11

Active since

2004

Affiliations

Duke Medical Center(Current)

Duke University Hospital

Duke University

National Institutes of Health

National Cancer Institute

Vidyalakshmi Chandramohan is an author at Duke Medical Center specializing in oncology, cancer immunotherapy, and glioblastoma immunotherapy.

Publications per year

2004–2023

15

Publications

15

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen E. Rhodin et al. · Clinical Cancer Research · 2018 · 646 citations

, , +17

CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

Satoshi Shiina, Masasuke Ohno, Fumiharu Ohka et al. · Cancer Immunology Research · 2016 · 109 citations

, , +17

Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas

Yukinari Kato, Ganesan Vaidyanathan, Mika K. Kaneko et al. · Nuclear Medicine and Biology · 2010 · 104 citations · Full text

, , +14

Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

Vidyalakshmi Chandramohan, Xuhui Bao, Mika K. Kaneko et al. · International Journal of Cancer · 2012 · 76 citations · Full text

, , +17

Reciprocal Control of Forkhead box O 3a and c-Myc via the Phosphatidylinositol 3-Kinase Pathway Coordinately Regulates p27Kip1 Levels

Vidyalakshmi Chandramohan, Sébastien Jeay, Stefania Pianetti et al. · The Journal of Immunology · 2004 · 75 citations

, , +17

1–5 of 15